# Pharmacogenomics of the Variability in the In Vivo Response to Glucocorticoids

> **NCT03023891** · PHASE1 · COMPLETED · sponsor: **Vanderbilt University Medical Center** · enrollment: 25 (actual)

## Conditions studied

- Glucocorticoids Toxicity
- Glucose Intolerance

## Interventions

- **DRUG:** Prednisone

## Key facts

- **NCT ID:** NCT03023891
- **Lead sponsor:** Vanderbilt University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-15
- **Primary completion:** 2019-01-10
- **Final completion:** 2019-12-31
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2020-06-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03023891

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03023891, "Pharmacogenomics of the Variability in the In Vivo Response to Glucocorticoids". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT03023891. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*